← Evidence map

ArticleToxicology reports2022

A phase I clinical trial to evaluate the safety of thymoquinone-rich black cumin oil (BlaQmax®) on healthy subjects: Randomized, double-blinded, placebo-controlled prospective study.

Jestin V Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36518481